AI drug discovery firm raises $5 billion

Published · Updated · Based on reporting by TechCrunch

Isomorphic Labs has secured $5 billion in a Series C funding round. The AI drug-discovery platform was spun out of Google’s DeepMind in 2021. This capital injection will support the company as it prepares to take drug candidates to clinical trials. The round marks a significant milestone for the startup.

Background

The company was established in 2021 after spinning out of Google’s DeepMind.

Why it matters

The funding will accelerate the development of new treatments using artificial intelligence.

Read the full coverage

More on: AI · Startups & Funding · #IsomorphicLabs · #Google · #DeepMind

This brief was written with AI from the headlines and excerpts published by the outlets above, and may contain errors. Follow the links for the original reporting.